S. 480: National All Schedules Prescription Electronic Reporting Reauthorization Act of 2016
Before you vote › Federal bills
S. 480: National All Schedules Prescription Electronic Reporting Reauthorization Act of 2016
114th Congress · introduced 2015-02-12 · Health · Latest: Placed on Senate Legislative Calendar under General Orders. Calendar No. 440.
federal
Follow this bill, step by step
- Where it came from: introduced 2015-02-12 · official record
- Who proposed it: Sen. Shaheen, Jeanne [D-NH] · what a sponsor is
- What happened next: no floor votes in our records yet. Why?
- Where it stands now: Placed on Senate Legislative Calendar under General Orders. Calendar No. 440. Not final yet: this can still change. We check for updates every day.
- If it becomes law and spends money: follow the money to money laws, then agencies and contracts and grants.
Official title
National All Schedules Prescription Electronic Reporting Reauthorization Act of 2016
Plain summary
National All Schedules Prescription Electronic Reporting Reauthorization Act of 2016 (Sec. 3) This bill amends the Public Health Service Act to revise and extend through FY2021 the controlled substance monitoring program, including to: allow grants to be used to maintain existing state controlled substance monitoring programs; require the Department of Health and Human Services (HHS) to redistribute any funds that are returned among the remaining grantees; require states to report on the interoperability of their programs with federal programs and health information technology systems and whether their programs provide automatic, up-to-date, or daily information about a patient upon request; require states to provide HHS with aggregate data and other information to enable HHS to evaluate the success of state programs; and expand the program to include any commonwealth or territory of the United States. The Drug Enforcement Administration, HHS, a state Medicaid program, a state health department, or a state substance abuse agency receiving nonidentifiable information from a controlled substance monitoring database for research purposes may make that information available to other entities for research purposes. HHS is no longer required to give preference for grants related to drug abuse to states with controlled substance monitoring programs. A state receiving a grant for a controlled substance monitoring program must: (1) facilitate prescriber and dispenser use of the controlled substance monitoring system, and (2) educate prescribers and dispensers on the benefits of the system.
Congressional Research Service summary (Reported to Senate with amendment(s)), quoted unchanged (nonpartisan). Read the source.
What a vote does
A “Yea” vote
If it passes both chambers and is signed, it becomes law.
A “Nay” vote
If it is not passed, current law stays as it is.
PSI Sci description of the legislative step (not an opinion).
What does this mean? (plain words)
Official text
National All Schedules Prescription Electronic Reporting Reauthorization Act of 2016
Source: Congressional Research Service summary (Reported to Senate with amendment(s))
AI explanation – may be wrong, check the official text
No AI explanation yet. It takes up to a minute to write and is then saved for everyone.
Limited to a few requests an hour per person.
The strongest published arguments
Arguments for (supporters)
Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.
Arguments against (opponents)
Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.
Alternatives
Needs sources: no published alternatives yet (for example a different bill, a law instead of an amendment, or keeping current law). We only show items backed by a published source. Suggest one.
How did my representative vote? · This bill's floor votes
Officials and money
Sponsor: Sen. Shaheen, Jeanne [D-NH] · 12 cosponsors
Cost estimate: No cost estimate published yet.
Cosponsors on this site
Richard J. Durbin (D-IL), Kirsten E. Gillibrand (D-NY), Edward J. Markey (D-MA), Charles E. Schumer (D-NY), Elizabeth Warren (D-MA), Richard Blumenthal (D-CT), Susan M. Collins (R-ME)
Sponsor's campaign money: Sen. Shaheen, Jeanne [D-NH] reported raising $176,810 (2025–2026). Details. Shown for context only; it does not mean any donor supported this bill.
No linked floor roll calls in our collected records yet. This does not mean the bill has never had a vote. Check the official bill history.
Words on this page, explained (1)
- Bill
- A proposed law. It becomes law only if it passes the legislature and is signed by the president or governor (or a veto is overridden).
Plain meanings written from linked sources. All words.
Sources
- Congressional Research Service summary (Reported to Senate with amendment(s))
- Congress.gov
- Data: GovInfo BILLSTATUS bulk data (Library of Congress), BILLSTATUS-114s480.xml <https://www.govinfo.gov/bulkdata/BILLSTATUS/114/s>
Record fed-us-cong114-s480 · catalog fed-us-congress-bills-cong114 · updated 2026-11-15 by psicol fed-bills-cong114